Related Experiment Videos
Continuous hemodynamic monitoring in heart failure
Frieder Braunschweig1, Cecilia Linde
1Department of Cardiology, Karolinska Hospital, Stockholm, Sweden. frieder.braunschweig@ks.se
Insights
Continuous hemodynamic monitoring in chronic heart failure patients is safe and feasible. This technology offers reliable hemodynamic data for improved patient management and treatment optimization.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Chronic congestive heart failure presents significant morbidity, mortality, and healthcare costs.
- Increasing prevalence necessitates improved patient management strategies.
- Current management often lacks continuous, objective hemodynamic data.
Observation:
- Implantable devices enable continuous hemodynamic monitoring.
- This monitoring provides reliable central hemodynamic parameters.
- Long-term hemodynamic trends can be analyzed.
Findings:
- Continuous hemodynamic monitoring is technically feasible and safe.
- It offers valuable insights into hemodynamic status.
- Case study demonstrates utility during beta-blocker titration.
Implications:
- Potential to enhance management of chronic heart failure patients.
- Facilitates data-driven adjustments in therapies like diuretics and beta-blockers.
- Future applications in optimizing volume management and treatment strategies.
Abstract:
Chronic congestive heart failure is associated with high morbidity and mortality, frequent hospital admissions, and high treatment costs. As the prevalence and incidence of the disease are increasing, there is a clear need to improve the management of heart failure patients. Continuous hemodynamic monitoring with an implanted device is technically feasible and safe. It provides reliable information on central hemodynamic parameters and allows for analysis of long-term hemodynamic trends. It has been suggested that continuous hemodynamic monitoring might improve the management of patients with chronic heart failure. This article describes the technical details of the monitoring system and presents possible clinical applications, with a focus on beta-blocker therapy, diuretics, and volume management. A case is reported, illustrating how hemodynamic long-term trends might add valuable information during up-titration of beta-blockers. Future implications of hemodynamic monitoring are discussed.